AI-Powered Summary

Market Context

Top Queries

More News

Explore Prysm Tools

Related Stories

Sudeep Pharma Limited Files SEBI Compliance Certificate for Q3 FY26

Sudeep Pharma Limited

AI Sentiment Analysis

January 8, 2026, 09:51 AM

Top Queries to Ask About Sudeep Pharma Limited

Thinking to buy or sell Sudeep Pharma Limited? Ask AI before you act.

Users

Trusted by 5,000+ users

More Details on This News

Sudeep Pharma Limited has submitted a certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended December 31, 2025. The company's Registrar and Share Transfer Agent, MUFG Intime India Private Limited, issued this certificate.

According to the certificate, no demat requests were received for processing during the quarter, as all shares of Sudeep Pharma Limited are held in electronic mode only. This confirmation was provided by MUFG Intime India Private Limited on January 7, 2026, and Sudeep Pharma Limited has taken this on record on January 8, 2026.

See What Deep Dive Gives You — in Seconds

“what happens when you click Deep Dive “

Instant AI Summary - “Get clean, noise-free earnings breakdowns.”

PDF Insights - “Download detailed, AI-generated reports.”

Metrics Explained -“Key ratios & trends explained in simple language.”

Want to know if this news pushes your stock up or down?

Just tap

deep dive

More News on Sudeep Pharma Limited

Analyze Sudeep Pharma Limited

Discover more trending news on Prysm

View All